Cardiac progenitor cells (CPCs) remote as cardiospheres (CSs) and CS-derived cells (CDCs) are a appealing tool for cardiac cell therapy in heart failure patients, having CDCs already been used in a phase I/II medical trial. two offered ineffective cell yields, while one performed optimally, in terms of CPCs yield/phenotype. In summary, the use of HSs… Continue reading Cardiac progenitor cells (CPCs) remote as cardiospheres (CSs) and CS-derived cells